140 related articles for article (PubMed ID: 3626790)
1. Biodistribution of GdCl3 and Gd-DTPA and their influence on proton magnetic relaxation in rat tissues.
Barnhart JL; Kuhnert N; Bakan DA; Berk RN
Magn Reson Imaging; 1987; 5(3):221-31. PubMed ID: 3626790
[TBL] [Abstract][Full Text] [Related]
2. Influence of gadolinium chelates on phosphorus-31 magnetic resonance spectroscopy of the liver.
Bauer H; Negishi C; Weinmann HJ
Invest Radiol; 1994 Aug; 29(8):752-7. PubMed ID: 7960625
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the biodistribution of 153Gd-labeled Gd(DTPA)2-, Gd(DOTA)-, and Gd(acetate)n in mice.
Wedeking P; Tweedle M
Int J Rad Appl Instrum B; 1988; 15(4):395-402. PubMed ID: 3255735
[TBL] [Abstract][Full Text] [Related]
4. Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DTPA.
Strich G; Hagan PL; Gerber KH; Slutsky RA
Radiology; 1985 Mar; 154(3):723-6. PubMed ID: 3969477
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium cryptelates as MR contrast agents.
Knop RH; Frank JA; Dwyer AJ; Girton ME; Naegele M; Schrader M; Cobb J; Gansow O; Maegerstadt M; Brechbiel M
J Comput Assist Tomogr; 1987; 11(1):35-42. PubMed ID: 3805426
[TBL] [Abstract][Full Text] [Related]
6. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
[TBL] [Abstract][Full Text] [Related]
7. Comparison of initial biodistribution patterns of Gd-DTPA and albumin-(Gd-DTPA) using rapid spin echo MR imaging.
Schmiedl U; Moseley ME; Ogan MD; Chew WM; Brasch RC
J Comput Assist Tomogr; 1987; 11(2):306-13. PubMed ID: 3102572
[TBL] [Abstract][Full Text] [Related]
8. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue.
Donahue KM; Burstein D; Manning WJ; Gray ML
Magn Reson Med; 1994 Jul; 32(1):66-76. PubMed ID: 8084239
[TBL] [Abstract][Full Text] [Related]
9. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC
Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
[TBL] [Abstract][Full Text] [Related]
10. Gd-DOTA: characterization of a new paramagnetic complex.
Bousquet JC; Saini S; Stark DD; Hahn PF; Nigam M; Wittenberg J; Ferrucci JT
Radiology; 1988 Mar; 166(3):693-8. PubMed ID: 3340763
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution and clearance of liposomal gadolinium-DTPA.
Unger E; Cardenas D; Zerella A; Fajardo LL; Tilcock C
Invest Radiol; 1990 Jun; 25(6):638-44. PubMed ID: 2354925
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of two new gadolinium chelates as contrast agents for MRI.
Wiegers CB; Welch MJ; Sharp TL; Brown JJ; Perman WH; Sun Y; Motekaitis RJ; Martell AE
Magn Reson Imaging; 1992; 10(6):903-11. PubMed ID: 1461088
[TBL] [Abstract][Full Text] [Related]
13. Gadolinium-DTPA liposomes as a potential MRI contrast agent. Work in progress.
Unger E; Needleman P; Cullis P; Tilcock C
Invest Radiol; 1988 Dec; 23(12):928-32. PubMed ID: 3203995
[TBL] [Abstract][Full Text] [Related]
14. Concentration of gadolinium-diethylene triamine pentaacetic acid in human kidney--study on proper time for dynamic magnetic resonance imaging of the human kidney on low and high magnetic fields.
Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T; Tanikawa T; Sato S
Tohoku J Exp Med; 1993 Oct; 171(2):119-28. PubMed ID: 8128480
[TBL] [Abstract][Full Text] [Related]
15. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
[TBL] [Abstract][Full Text] [Related]
16. Elimination of gadolinium-ethoxybenzyl-DTPA in a rat model of severely impaired liver and kidney excretory function. An experimental study in rats.
Mühler A; Heinzelmann I; Weinmann HJ
Invest Radiol; 1994 Feb; 29(2):213-6. PubMed ID: 8169100
[TBL] [Abstract][Full Text] [Related]
17. Aerosolized gadolinium-DTPA enhances the magnetic resonance signal of extravascular lung water.
Montgomery AB; Paajanen H; Brasch RC; Murray JF
Invest Radiol; 1987 May; 22(5):377-81. PubMed ID: 3597005
[TBL] [Abstract][Full Text] [Related]
18. Biliary excretion and pharmacokinetics of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging in the rat.
Schuhmann-Giampieri G; Schmitt-Willich H; Frenzel T; Schitt-Willich H [corrected to Schmitt-Willich H]
J Pharm Sci; 1993 Aug; 82(8):799-803. PubMed ID: 8377117
[TBL] [Abstract][Full Text] [Related]
19. Ni-DTPA doped agarose gel--a phantom material for Gd-DTPA enhancement measurements.
Tofts PS; Shuter B; Pope JM
Magn Reson Imaging; 1993; 11(1):125-33. PubMed ID: 8423715
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues.
Wang SC; Wikström MG; White DL; Klaveness J; Holtz E; Rongved P; Moseley ME; Brasch RC
Radiology; 1990 May; 175(2):483-8. PubMed ID: 1691513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
